Underuse of cardiorenal protective agents in high-risk diabetes patients in primary care: a cross-sectional study

BACKGROUND: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) have shown benefits in patients with diabetes and cardiovascular disease (CVD), heart failure (HF), and chronic kidney disease (CKD). OBJECTIVE: We assessed benchmark outcomes (Hemo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Robin, Myroniuk, Tyler, McGuckin, Taylor, Manca, Donna, Campbell-Scherer, Denise, Lau, Darren, Yeung, Roseanne O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128222/
https://www.ncbi.nlm.nih.gov/pubmed/35606699
http://dx.doi.org/10.1186/s12875-022-01731-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128222/
https://www.ncbi.nlm.nih.gov/pubmed/35606699
http://dx.doi.org/10.1186/s12875-022-01731-w

Ejemplares similares